Brief: Palvella Therapeutics And Pieris Pharmaceuticals Announce Definitive Merger Agreement

Palvella Therapeutics

24/07/2024 11:50

July 24 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PALVELLA THERAPEUTICS AND PIERIS PHARMACEUTICALS ANNOUNCE
DEFINITIVE MERGER AGREEMENT
    * PIERIS PHARMACEUTICALS INC - TO ISSUE SHARES OF PIERIS
COMMON
STOCK TO PRE-MERGER PALVELLA STOCKHOLDERS AS MERGER
CONSIDERATION
    * PIERIS PHARMACEUTICALS INC - PALVELLA TO BECOME
WHOLLY-OWNED
UNIT OF CO
    * PIERIS PHARMACEUTICALS - PRE-MERGER PIERIS STOCKHOLDERS
WILL OWN
ABOUT 18% OF COMBINED COMPANY
    * PIERIS PHARMACEUTICALS - PRE-MERGER PALVELLA STOCKHOLDERS
WILL
OWN APPROXIMATELY 82% OF COMBINED COMPANY ON A PRO FORMA BASIS
    * PIERIS PHARMACEUTICALS- COMBINED COMPANY TO BE LED BY WES
KAUPINEN & OTHER MEMBERS OF PALVELLA MANAGEMENT TEAM

Source text for Eikon:  ID:n0001437749-24-023301 
Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))